Patent ID: 9408926
Filing Date: 2016-08-09
CPC Classification: A61K,A61P,C07K

Claim Text:
1. A method for adjusting a treatment protocol comprising: (a) administering an ultrasound contrast agent comprising a KDR binding polypeptide having a sequence selected from the group consisting of: to a subject with a disorder associated with cell hyperproliferation or angiogenesis; (b) obtaining an initial image of the subject; (c) administering a therapeutic agent appropriate for the treatment of the disorder; (d) obtaining a subsequent image of the subject; (e) comparing the initial and the subsequent images to evaluate the effectiveness of the therapy; (f) determining whether the effectiveness of the therapy is adequate; and (g) if the effectiveness of the therapy is determined not to be adequate, adjusting said treatment protocol, terminating said treatment protocol or administering a different treatment protocol.